The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...
Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...
The Food and Drug Administration has upgraded its classification of a broccoli recall initially reported in late December, ...
Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...
The head of the FDA’s artificial intelligence-focused Digital Center of Excellence, Troy Tazbaz, is departing the agency, ...
The Trump administration ordered an immediate pause on public communications from federal health agencies like the CDC, FDA, ...
Brenner, who has worked in the FDA’s Center for Devices and Radiological Health, will lead the agency until a permanent ...
The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...
The number of hospitalizations and deaths from foodborne illness doubled last year compared to 2023 in the U.S.